Do you want to read an article? Please log in or register.
Artificial Intelligence in neovascular age-related macular degeneration
Macular DiseasesFurther Publications
Related content
Macular DiseasesFurther Publications
Artificial Intelligence-Based Disease Activity Monitoring to Personalized Neovascular Age-Related Macular Degeneration Treatment: A Feasibility Study
Ophthalmol Sci
Mulyukov Z, Keane PA, Sahni J, Liakopoulos S, Hatz K, Wei Ting DS, Gallego-Pinazo R, Aslam T, Gemmy Cheung CM, De Salvo G, Semoun O, Somfai GM, Stahl A, Lujan BJ, Lorand D
doi: 10.1016/j.xops.2024.100565
Macular Diseases
Fluid fluctuations assessed with artificial intelligence during the maintenance phase impact anti-vascular endothelial growth factor visual outcomes in a multicentre, routine clinical care national age-related macular degeneration database
Br J Ophthalmol
Martin-Pinardel R, Izquierdo-Serra J, Bernal-Morales C, De Zanet S, Garay-Aramburu G, Puzo M, Arruabarrena C, Sararols L, Abraldes M, Broc L, Escobar-Barranco JJ, Figueroa M, Zapata MA, Ruiz-Moreno JM, Parrado-Carrillo A, Moll-Udina A, Alforja S, Figueras-Roca M, Gómez-Baldó L, Ciller C, Apostolopoulos S, Mishchuk A, Casaroli-Marano RP, Zarranz-Ventura J, from the FRB SPAIN-IMAGE Project Investigators
doi: 10.1136/bjo-2024-325615
RECOMMENDED
Macular Diseases
Macular Atrophy in Neovascular Age-Related Macular Degeneration: A Systematic Review and Meta-Analysis
★ 3
Recommended by
Prof. emer. Dr Josef Flammer, Faculty Member
Ophthalmol Retina
Berni A, Coletto A, Li J, Shen M, Bandello F, Reibaldi M, Borrelli E
doi: 10.1016/j.oret.2025.01.011
Macular Diseases
Cross-instrument optical coherence tomography-angiography (OCTA)-based prediction of age-related macular degeneration (AMD) disease activity using artificial intelligence
Sci Rep
Heinke A, Zhang H, Broniarek K, Michalska-Małecka K, Elsner W, Galang CMB, Deussen DN, Warter A, Kalaw F, Nagel I, Agnihotri A, Mehta NN, Klaas JE, Schmelter V, Kozak I, Baxter SL, Bartsch DU, Cheng L, An C, Nguyen T, Freeman WR
doi: 10.1038/s41598-024-78327-0
Macular DiseasesFurther Publications
Subretinal fibrosis occurrence according to macular neovascularisation subtypes in neovascular age-related macular degeneration
Acta Ophthalmol
Lenhof S, Kodjikian L, Gascon P, Gadiollet E, Feldman A, De Bats F, Wolff B, Pradat P, Mathis T
doi: 10.1111/aos.16759
Macular Diseases
Cost-minimisation analysis of anti-VEGF therapies in neovascular age-related macular degeneration and diabetic macular oedema in Switzerland
J Med Econ
Ambresin A, Quist SW, Boer M, Maamari S, Barthelmes D
doi: 10.1080/13696998.2025.2536420
Macular Diseases
Incidence and reasons for discontinuation of anti-VEGF treatment in neovascular age-related macular degeneration
Br J Ophthalmol
Borrelli E, Foti C, Ulla L, Porreca A, Introini U, Grassi MO, Viggiano P, Peronetti M, Toscani R, Boscia G, Termite AC, Gennaro C, Marolo P, Boscia F, Bandello F, Reibaldi M
doi: 10.1136/bjo-2024-326152
Macular Diseases
Outlier ophthalmologists in the treatment of neovascular age-related macular degeneration with intravitreal therapy
Br J Ophthalmol
Hashimoto Y, Hunt AR, Wells JM, Banerjee G, Ferrier R, Barry R, Field A, Game J, Hooper CY, Barthelmes D, Gillies MC
doi: 10.1136/bjo-2024-326024
Macular Diseases
Acceptance of the Disease in Patients Diagnosed with Neovascular Age-Related Macular Degeneration Depending on Visual Parameters-Before and After a Series of Seven Intravitreal Injections
J Clin Med
Nowak M, Cybulska AM, Schneider-Matyka D, Grochans E, Walaszek I, Panczyk M, Nowicki GJ, Rachubińska K
doi: 10.3390/jcm14020447